Main article

The 13 publicly traded labs tracked by G-2 Reports’ Laboratory Stock Index continue to struggle in early 2010.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

March 2010 - Table of Contents

Industry Buzz: MedPAC Considers Removing Some Lab Tests from In-Office Ancillary Services Exception

Lab Index Continues Winter Slump; Down 10% Over Last Five Weeks

Time Ticking as Physician Fee Cut Freeze Expires on March 1; Congress’s Next Move Remains Unclear

Carilion-Spectrum Merger to Shake Up Lab Industry’s Duopolistic Stronghold in Mid-Atlantic and Southern Regions

LabCorp’s Q409 Revenues Up 3.4% to $1.16 Billion; Economy Still Challenges Volume Growth in 2010

Inside the Lab Industry: Managing Risk in Lab Sales and Marketing: Nine Rules to Sell By

Bostwick Shutters AIPL after Only Six Months; Announces Tenn. Closure

Myriad Genetics Emerges as Early Leader in G-2’s Preliminary FY09 Benchmarking Analysis

Baylor Health Care Launches Joint Venture with US Oncology

Oral Arguments Heard in Gene Patents Lawsuit

LIR March 2010 (Full PDF Issue)